Viewing Study NCT02739412


Ignite Creation Date: 2025-12-26 @ 11:12 PM
Ignite Modification Date: 2026-03-01 @ 12:32 PM
Study NCT ID: NCT02739412
Status: COMPLETED
Last Update Posted: 2022-12-19
First Post: 2016-04-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy of Low Dose, SubQ Interleukin-2 (IL-2) to Expand Endogenous Regulatory T-Cells in Liver Transplant Recipients
Sponsor: Beth Israel Deaconess Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Liver Transplantation View
Keywords: